President and CEO of Pharmaceutics International, Inc. (Pii), John Fowler, reacts to the agility and flexibility needed to support the development and manufacture of today's complex biotherapeutics.
Watch the video and learn more about:
Services necessary to carry out new programs for complex molecules, from scale-up to commercialization.
Lyophilization capabilities that can help ensure quality through processing.
Resources to support efficient secondary pharmaceutical packaging.